Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06052969 · ClinicalTrials.gov registry record · NA
Pulse Endovascular ReperFUSION for Acute Ischemic Stroke
A NA study of Acute Ischemic Stroke AIS and Cerebral Arterial Disease, sponsored by Euphrates Vascular.
- Recruiting
- Registry status
- NA
- Development phase
- 8
- Enrollment target
- 1
- Study location
NCT06052969: Recruiting NA study of Acute Ischemic Stroke AIS and Cerebral Arterial Disease, sponsored by Euphrates Vascular.
NCT06052969 is a NA study of Acute Ischemic Stroke AIS and Cerebral Arterial Disease that is actively recruiting participants, run by Euphrates Vascular. The registered enrollment target is 8 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06052969, a NA study of Acute Ischemic Stroke AIS and Cerebral Arterial Disease, is actively recruiting participants, sponsored by Euphrates Vascular.
- RECRUITING
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
- 1
- Study location
Study Summary
Prospective, multi-center, single-arm early feasibility study enrolling a minimum of 15 subjects at up to a minimum of 3 active investigational sites in the United States. The subjects must be diagnosed with acute ischemic stroke (AIS), must be post-mechanical thrombectomy, will have had intravenous thrombolytics, and have a visible MCA, ACA or PCA occlusive clot on initial angiographic imaging. Each subject will receive the Pulse NanoMED procedure after attempted neurovascular therapy to achieve better reperfusion.
Primary Outcome
To test the safety and feasibility of the Pulse NanoMED System in ischemic stroke patients. The potential clinical benefit of early recanalization will be visually assessed by a core laboratory by comparing baseline DSA, CTA, or MRA images with images taken at set timepoints.
Conditions Studied
Interventions
- DEVICE Pulse NanoMED System
Study Locations (1)
South Carolina
- University of South Carolina - Prisma - Columbia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2023-10-01 |
| Est. Completion | 2026-03-15 |
| Phase | NA |
What NCT06052969 shows while recruiting
NCT06052969 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Acute Ischemic Stroke AIS appearing as the primary indexed condition, and to 1 intervention - of which Pulse NanoMED System is the first listed.
NCT06052969 reports a single indexed study location in South Carolina.
Frequently Asked Questions
What is clinical trial NCT06052969 about?
NCT06052969 is a clinical study titled "Pulse Endovascular ReperFUSION for Acute Ischemic Stroke". Prospective, multi-center, single-arm early feasibility study enrolling a minimum of 15 subjects at up to a minimum of 3 active investigational sites in the United States. The subjects must be diagnosed with acute ischemic stroke (AIS), must be post-mechanical thrombectomy, will have had intravenou...
What is the current status of trial NCT06052969?
This trial is currently recruiting. It is a NA study. The enrollment target is 8 participants. The study started on 2023-10-01. Estimated completion is 2026-03-15.
What conditions does trial NCT06052969 study?
This clinical trial studies the following conditions: Acute Ischemic Stroke AIS, Cerebral Arterial Disease.
What interventions are being tested in trial NCT06052969?
The interventions under investigation include: Pulse NanoMED System (DEVICE).
Who is sponsoring clinical trial NCT06052969?
This trial is sponsored by Euphrates Vascular, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06052969 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Ischemic Stroke AIS
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06052969's enrollment target sits among peer trials
8 1976th of 2000 higher than 19 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI